Congress trades

Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ · Healthcare · 6 congress trades · last filed 3 months ago

6
Congress disclosures shown
39d
Median delay on the congress disclosures
of the 45 day limit
5/1
Purchases and sales in the disclosures shown

About Ligand Pharmaceuticals Incorporated

from the company's filings and listing
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Chief executive
Todd C. Davis
Employees
47
Listed since
Nov 18, 1992
Market value
$5.8B
Price to earnings
28.8
Earnings per share
$9.83
Dividend yield
-

www.ligand.com

Earnings

6 reported quarters · next on Nov 5, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 6, 2026$2.37$2.01$63.7M$61.3MEPS beatRevenue beat
Q1 FY2026reported May 14, 2026$1.63$1.84$51.7M$59.1MEPS missRevenue miss
Q4 FY2025reported Feb 26, 2026$2.02$1.46$59.7M$55.6MEPS beatRevenue beat
Q3 FY2025reported Nov 6, 2025$3.09$1.97$115.5M$58.7MEPS beatRevenue beat
Q2 FY2025reported Aug 7, 2025$1.60$1.42$47.6M$43.9MEPS beatRevenue beat
Q1 FY2025reported May 8, 2025$1.33$1.21$45.3M$38.7MEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2024 · proxy filed Apr 22, 2025
ExecutiveSalaryStock awardsOtherTotal
Todd C. DavisChief Executive Officer$696K$6.4M$5.8M$12.9M
Tavo EspinozaChief Financial Officer$470K$1.4M$1.4M$3.3M
Andrew ReardonChief Legal Officer and Secretary$452K$1.4M$1.4M$3.3M

The summary compensation table from the 2024 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$980.2M3,100,996+4.7%15.46%
Invesco Ltd.$379.8M1,201,644+45.9%5.99%
Vanguard Portfolio Management LLC$359.8M1,138,316+3.5%5.67%
Jupiter Topco LLC$328.9M1,040,578+100.0%5.19%
Vanguard Capital Management LLC$275.3M870,950+2.7%4.34%
State Street Corp$261.3M826,539+6.1%4.12%
FMR LLC$241.1M762,827+28.0%3.80%
Franklin Resources Inc$237.7M752,044+31.2%3.75%
Congress Asset Management Co /Ma$208.6M659,911+30.8%3.29%
Geode Capital Management, LLC$186.2M589,020+5.4%2.94%
Macquarie Management Holdings, Inc.$179.7M568,371-0.9%2.83%
Chicago Capital, LLC$174.9M553,435-1.5%2.76%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next LGND filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in LGND

6 disclosures of 6 on record · median 39d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+24.2%S&P +0.8% · vs S&P 500 +23.4%May 29, 2026Jun 8, 202610d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+41.0%S&P +12.0% · vs S&P 500 +29.0%Mar 3, 2026Apr 7, 202635d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+46.9%S&P +10.1% · vs S&P 500 +36.8%Jan 15, 2026Feb 13, 202629d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+50.0%S&P +10.8% · vs S&P 500 +39.2%Jan 5, 2026Feb 13, 202639d
Katherine M. ClarkSpouseStockSale$1,001 - $15,000+239.9%S&P +121.4% · vs S&P 500 +118.5%Oct 22, 2020Dec 3, 202042d
Katherine M. ClarkSpouseFiled lateStockPurchase$1,001 - $15,000+293.4%S&P +207.4% · vs S&P 500 +86.0%Apr 3, 2020May 29, 202056d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Members of Congress reporting a position

1 member · estimate, as of Sep 10, 2026

1 member reports a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Gilbert Ray Cisneros, Jr.Democrat · House$15,001 - $50,0000.1%

Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Questions

Which members of Congress have traded LGND?

Gilbert Ray Cisneros, Jr., Katherine M. Clark disclosed LGND transactions in the filings shown here.

Which members of Congress hold LGND?

1 member of Congress reports a position in LGND in the estimate we hold as of Sep 10, 2026. The largest estimated position belongs to Gilbert Ray Cisneros, Jr.. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

How quickly are LGND trades disclosed?

Congressional disclosures took a median of 39 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days late, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track